Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 18, 2020
Pfizer and BioNTech have announced their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the study’s primary efficacy endpoints.
read more
Tuesday, November 10, 2020
Novasep is investing €6.5 million to expand capacity & increase flexibility in an API manufacturing workshop at its Chasse-sur-Rhône site.
read more
Friday, November 06, 2020
Flamma has entered into an agreement with Gilead earlier this year to be part of the network of manufacturers contributing to the Veklury (remdesivir) supply chain.
read more
Tuesday, November 03, 2020
Protagonist Therapeutics announced two additional oral peptide IL-23 receptor antagonist candidates from its collaboration agreement with Janssen Biotech have been selected for advancement into clinical development.
read more
Monday, November 02, 2020
Quantum Genomics has entered into an exclusive licensing and collaboration agreement with Xediton to develop and commercialize firibastat in Canada.
read more
AMRI has been named as the exclusive supplier of the API in Cassiopea SpA’s recently approved acne treatment, Winlevi cream 1%.
read more
Wednesday, October 21, 2020
Vifor and Cara announced both companies have signed a license agreement for commercialization of Korsuva (difelikefalin) Injection.
read more
Wednesday, October 07, 2020
BIAL and Recipharm, have expanded a long-term agreement for the global manufacturing and supply of BIAL’s proprietary molecule opicapone.
read more
Wednesday, September 30, 2020
Hovione announced the signing of a partnership agreement with Ligand to ramp up the production output of Captisol.
read more
Monday, September 28, 2020
Samsung Biologics has entered into a service agreement with Panolos Bioscience to develop PB101, an Fc-fusion protein intended to treat solid tumors.
read more
Monday, September 07, 2020
PAI announced the company has been awarded a three-year contract from HealthTrust Purchasing Group as a supplier of pharmaceutical products to its Membership nationwide.
read more
Monday, September 07, 2020
PPD and LT have entered into a collaboration to expand and enhance lupus clinical research for PPD’s pharmaceutical and biotech customers.
read more
Friday, September 04, 2020
RedHill announced the selection of opaganib1 for severe COVID-19 pneumonia.
read more
Wednesday, September 02, 2020
The FDA and the FTC has issued a warning letter to Lattice Biologics for marketing an unapproved amniotic fluid product, sometimes referred to as AmnioBoost.
read more
Tuesday, September 01, 2020
Gilead Sciences announced an agreement with Jounce Therapeutics to exclusively license its JTX-1811 program.
read more